SOURCE: SpectraScience, Inc.

May 09, 2011 09:26 ET

SpectraScience to Host Shareholder Update Call on May 19, 2011 at 2:00pm Pacific Time

CEO Michael Oliver to Provide Updates and Discuss Business Plan Initiatives for FY11

SAN DIEGO, CA--(Marketwire - May 9, 2011) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that it will hold a conference call to provide a general corporate update on Thursday, May 19, 2011 at 2:00pm Pacific Time / 5:00 pm Eastern Time.

The management team will host the conference call to discuss various operational updates and highlights in addition to discussing progress towards attaining corporate goals and initiatives for the remainder of fiscal year 2011.

To attend the call, please use the dial in information below. When prompted, ask for the "SpectraScience Investor Update Conference Call" and / or be prepared to provide the conference ID.

Conference Call

Date:
Thursday, May 19, 2011

Time:
2:00 pm Pacific Time

Toll Free Conference Line Dial-In (U.S.)
1-877-941-1428

Toll Free International Dial-In:
1-480-629-9665

Conference ID:
4439819

Please dial in at least 10 minutes before the call to ensure timely participation. A playback of the call will be available from 8:00 pm Eastern Time on May 19, 2011 until 11:59 pm Eastern Time on June 2, 2011. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517 when calling internationally. Please use the replay pin number 4439819.

About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

Contact Information

  • Contact:
    SpectraScience, Inc.
    Jim Dorst
    Chief Financial Officer
    (858) 847-0200 x2019

    Hayden Communications
    Investor Relations
    Todd Pitcher
    (858)-518-1387